What is the combination of medications contained in PrandiMet?

PrandiMet is a combination medication specifically designed for the treatment of type 2 diabetes. The correct combination of medications in PrandiMet is metformin and repaglinide. Metformin is an oral biguanide that works primarily by reducing hepatic glucose production and improving insulin sensitivity. Repaglinide is a meglitinide that stimulates the pancreas to secrete insulin, particularly after meals.

Together, these two medications effectively help manage blood glucose levels. Metformin addresses overall glucose control throughout the day, while repaglinide provides prompt insulin release in response to food intake, which is especially useful for postprandial glucose management. This synergistic effect allows for a more comprehensive approach to controlling blood sugar levels in individuals with type 2 diabetes.

In contrast, the other combinations listed do not correspond with the components of PrandiMet and serve different purposes in diabetes management. Understanding the components and their effects aids in recognizing the appropriate use of each medication in treatment strategies.